Data / Form D filings / Ikena Oncology, Inc.
Ikena Oncology, Inc.: Form D filings
Ikena Oncology, Inc., a biotechnology company in Boston, MA, filed 2 Form D notices with the SEC between 2023 and 2025. The latest, on July 18, 2025, reports an offering of $75 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 645 Summer Street, Suite 101, Boston, MA, 02210
- Phone
- (857) 273-8343
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1835579
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 18, 2025 | New notice | $75,000,000 | $0 | $75,000,000 | 0 | Yet to occur | sec.gov |
| Aug 18, 2023 | New notice | $42,571,751 | $42,571,751 | 48 | Aug 4, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard Wooster | Director | |
| Otello Stampacchia | Director | |
| Jotin Marango | Executive Officer | |
| Jean-Francois Formela | Director | |
| Mark Manfredi | Executive Officer, Director | |
| Jeffrey Ecsedy | Executive Officer | |
| Owen Hughes | Director | |
| Iain Dukes | Director | |
| Maria Koehler | Director | |
| David Bonita | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 14, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ikena Oncology, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.